Navigation Links
Apples keep lung disease away

According to researchers, smokers who eat lots of fruit and vegetables are less likely to develop chronic lung disease. Over 90 per cent of those with chronic obstructive pulmonary disease (COPD) are smokers or ex-smokers. But only one in five smokers// actually develop COPD - so there must be influences that mitigate this risk factor, either genetic, lifestyle or environmental.

Researchers at the University of Southampton, UK, have carried out the first study into diet and COPD in smokers. They find that those who eat a diet rich in fruits and vegetables are at reduced risk. Specifically, those who ate more than three apples a week enjoyed protection from COPD. These were smokers consuming at least one pack of cigarettes a day.

It may be that antioxidants in fruits and vegetables can counteract the harmful free radicals in cigarette smoke, and so preserve the health of the lungs. So here's another reason to keep up your fruit and vegetable intake. But, of course, the best way to avoid COPD is to give up smoking.


'"/>




Page: 1

Related medicine news :

1. Organic Farming May Increase The Output Of Apples In Himachal
2. Pick Apples for Good Neurological Health, Says New Research
3. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
4. Fight Heart disease and Pain with Meditation
5. Heart disease in the newborn is related to maternal malnutrition
6. Starvation in pregnant women can cause heart disease to their children
7. Individuals with sleep related breathing disorders more prone to heart disease
8. And now they say infections can cause heart disease!!!!
9. And now they say infections can cause heart disease!!!!
10. India takes on foot-and-mouth disease by vaccinating animals
11. Ticks may cause more diseases
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Apples keep lung disease away

(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...or obese is not only a personal issue that affects...at impacts other people in society. A new study in...at the extra Medicare cost associated with overwei...cial burden on tax payers, costing up to hundreds ...edicare population. , The article,s findings sh...
(Date:7/25/2008)...y.com announces the,availability of Trade Alerts o...ll of the daily trading notes for free by visiting...ts include: DUSA Pharmaceuticals Inc. (Nasdaq: DU...BRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp. (...and,Abaxis Inc. (Nasdaq: ABAX )., Join investor ...
(Date:7/25/2008)...ense and Federal Agencies in, the execution of Op...s a, four-day, multi-agency collaborative traini...cal agencies with large and complex incident respo...d-hoc, secure mobile communications infrastructu... Va., July 25 /PRNewswire/ -- Dataline LLC is plea...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
...genital herpes infections has decreased in the las...chers said this drop is due to changes in sexual b...tion between 1988-1994 and 1999-2004 and found tha...es was down from 21 percent to 17 percent. 'The m...
...onducted by Cancer Research UK finds that many wom...some women seem to genuinely forget to take their ...aking drugs. Difficulty in coping with side effec...s were given as main reasons for quitting the pill...
...e Lundy, who had to bear a miscarriage at an emerg...e launched by the health region to review emergenc... conducting the review and will begin the process ...mplaint after a shortage of beds in the emergency ...
...ch has been published in the journal Nature Neuros...heerful mouse’ might hold the key for treatment of...ined that TREK-1 is a gene that might affect trans...y explained that serotonin is known to play an imp...
Other Medicine News:Health News:A New Breed Of Mice Might Hold The Key For Depression Treatment 2
(Date:7/24/2008)...RNewswire-USNewswire/ -- Headlines claiming "soy,p...tory. The small scale,preliminary study that Dr. ...tion, is based on recollected intake of soyfoods a...s study is confounded by many,issues, thus I feel ...caution," warned Dr. Tammy Hedlund, a researcher i...
(Date:7/23/2008)...roved Systemic Therapy to Treat the Disease -, WA...ire-FirstCall/ --,Bayer HealthCare Pharmaceuticals...ay announced that The New England Journal of Medic...ting that Nexavar(R) (sorafenib),tablets decreased...nts with,unresectable hepatocellular carcinoma (HC...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...lts from a multi-center 293-patient European, tri...xchange Symbol: CYT, MONTREAL, July 22 /PRNewswir...global leader in cryotherapy products to treat car...viously presented from three,European study center...),were published earlier today in the Journal of ...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Spectral appoints Anthony Bihl to Board of Directors 3774 1Spectral appoints Anthony Bihl to Board of Directors 3774 2Smoking Boosts Bleeding Stroke Risk in Those With High Blood Pressure 13727 1Smoking Boosts Bleeding Stroke Risk in Those With High Blood Pressure 13727 2Rheumatoid Arthritis Drugs May Lower Heart Attack Stroke Risk 13725 1Rheumatoid Arthritis Drugs May Lower Heart Attack Stroke Risk 13725 2Function of molecular switch pinpointed in severe congenital neutropenia 13723 1Function of molecular switch pinpointed in severe congenital neutropenia 13723 2Function of molecular switch pinpointed in severe congenital neutropenia 13723 3
...es Positive Data in Nonclinical (IND) In- Vitro,St...ay 3, 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceu...drugs,is pleased to announce positive results wer...ical testing of Caprospinol (SP-233),with well re...esearch results are imperfect predictors,of clinic...
...., May 02, 2007 /PRNewswire/ -- Ceregene, Inc.,tod...trial of,CERE-110, a gene therapy product designed...tment of Alzheimer,s disease. After one,year of fo...ived,CERE-110 in the trial indicate that a single ...and an interim analysis suggested that,the therapy...
Other Medicine Technology:Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 2Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 4
Features the unique design Labcold rack with high ventillation capability to allow oxygen transfer to the platelets. Six levels of retractable stainless steel trays which can be removed and autoclave
Flatbed Agitator.
...nge of storage capacities. Delrin rollers and glid...oothly, eliminating the need for ball bearings whi...ted drawers with non-slip textured coating provide...,i.Series platelet agitators feature a built-in mo...
Platelet agitator.
Medicine Products: